Back to Journals » Therapeutics and Clinical Risk Management » Volume 9

Safe medication use based on knowledge of information about contraindications concerning cross allergy and comprehensive clinical intervention

Authors Li W, Zhu LL, Zhou Q

Received 31 December 2012

Accepted for publication 22 January 2013

Published 26 February 2013 Volume 2013:9 Pages 65—72

DOI https://doi.org/10.2147/TCRM.S42013

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 5

Wei Li,1 Ling-Ling Zhu,2 Quan Zhou3

1Division of Medical Affairs, 2Cadre Department, Division of Nursing, 3Department of Pharmacy, Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang, People's Republic of China

Background: An investigation of safety issues regarding information on contraindications related to cross allergy was conducted to promote clinical awareness and prevent medical errors in a 2200-bed tertiary care teaching hospital.
Methods: Prescribing information on contraindications concerning cross allergy was collected from an information system and package inserts. Data mining and descriptive analysis were performed. A risk register was used for project management and risk assessment. A Plan, Do, Check, Act cycle was used as part of continuous quality improvement. Records of drug counseling and medical errors were collected from an online reporting system. A pharmacist-led multidisciplinary team initiated an intervention program on cross allergy in August 2008.
Results: Four years of risk management at our hospital achieved successful outcomes, ie, the number of medical errors related to cross allergies decreased by 97% (10 cases monthly before August 2008 versus three cases yearly in 2012) and risk rating decreased significantly [initial risk rating:25 (high-risk) before August 2008 versus final risk rating:6 (medium-risk) in December 2012].
Conclusion: We conclude that comprehensive clinical interventions are very effective through team cooperation. Medication use has potential for safety risks if sufficient attention is not paid to contraindications concerning cross allergy. The potential for cross allergy involving drugs which belong to completely different pharmacological classes is easily overlooked and can be dangerous. Pharmacists can play an important role in reducing the risk of cross allergy as well as recommending therapeutic alternatives.

Keywords: clinical pharmacy, contraindications, cross allergy, prescribing information, risk management, safe medication use

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Weight-based dosing in medication use: what should we know?

Pan SD, Zhu LL, Chen M, Xia P, Zhou Q

Patient Preference and Adherence 2016, 10:549-560

Published Date: 12 April 2016

A stewardship intervention program for safe medication management and use of antidiabetic drugs

Zhao RY, He XW, Shan YM, Zhu LL, Zhou Q

Clinical Interventions in Aging 2015, 10:1201-1212

Published Date: 23 July 2015

The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection

Jin JF, Zhu LL, Chen M, Xu HM, Wang HF, Feng XQ, Zhu XP, Zhou Q

Patient Preference and Adherence 2015, 9:923-942

Published Date: 2 July 2015

Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy

Wang ZY, Chen M, Zhu LL, Yu LS, Zeng S, Xiang MX, Zhou Q

Therapeutics and Clinical Risk Management 2015, 11:449-467

Published Date: 19 March 2015

Personalized therapeutics for levofloxacin: a focus on pharmacokinetic concerns

Gao CH, Yu LS, Zeng S, Huang YW, Zhou Q

Therapeutics and Clinical Risk Management 2014, 10:217-227

Published Date: 27 March 2014

Appropriateness of administration of nasogastric medication and preliminary intervention

Zhu LL, Xu LC, Wang HQ, Jin JF, Wang HF, Zhou Q

Therapeutics and Clinical Risk Management 2012, 8:393-401

Published Date: 20 November 2012

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010